Empirical therapy for diabetic foot infections: are there clinical clues to guide antibiotic selection?
- 1 April 2007
- journal article
- Published by Elsevier in Clinical Microbiology & Infection
- Vol. 13 (4) , 351-353
- https://doi.org/10.1111/j.1469-0691.2007.01697.x
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Prevalence of methicillin-resistant Staphylococcus aureus in infected and uninfected diabetic foot ulcersClinical Microbiology & Infection, 2006
- Bacterial etiology of diabetic foot infections in South IndiaEuropean Journal of Internal Medicine, 2005
- Ertapenem versus piperacillin/tazobactam for diabetic foot infections (SIDESTEP): prospective, randomised, controlled, double-blinded, multicentre trialThe Lancet, 2005
- Diagnosis and Treatment of Diabetic Foot InfectionsClinical Infectious Diseases, 2004
- A report from the international consensus on diagnosing and treating the infected diabetic footDiabetes/Metabolism Research and Reviews, 2004
- Erfahrungen im Umgang mit hochresistenten Keimen bei Patienten mit diabetischem Fuß-Syndrom unter besonderer Berücksichtigung von MRSA-InfektionenDeutsche Medizinische Wochenschrift (1946), 2001
- Antibiotic selection for diabetic foot infections: A reviewThe Journal of Foot and Ankle Surgery, 2000
- Diabetic Foot Infections: Bacteriology and activity of 10 oral antimicrobial agents against bacteria isolated from consecutive casesDiabetes Care, 1996
- Foot Infections in Diabetic Patients: The Role of AnaerobesClinical Infectious Diseases, 1995
- The Fetid Foot: Lower-Extremity Infections In Patients with Diabetes MellitusClinical Infectious Diseases, 1979